Rita Shaughnessy is a Psychiatry physician affiliated with Translational Therapeutics. OpenAlex indexes 52 publications with 1,008 citations (h-index 16); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2418 E York St
Philadelphia, PA 191253006
Telephone
833-351-8255Provider last certified this registry record 14 Apr 2025.
Clinical trials
- Multidisciplinary Model of Nurse Midwife
Sponsor: Drexel University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
100%Benzodiazepine47.9%Clonazepam59%Alprazolam41%Part D<11 patientsCentral Nervous System Stimulant21.4%Dextroamphetamine-Amphetamine100%Part D<11 patients+ 3 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Neurodevelopmental Impact of Copy Number Variants in Patients With Treatment-Resistant Schizophrenia
Biological Research For Nursing
2026 - Delineating lifetime multimorbidity associated with 16p13.11 duplication: A literature review, meta-analysis, and case study
Progress in Neuro-Psychopharmacology and Biological Psychiatry
2025 - Medical Multimorbidity in Patients With Treatment‐Resistant Psychosis and Rare Copy Number Variants: A Retrospective Case Series of 24 Patients
American Journal of Medical Genetics Part A
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Steven Brem, MD
Translational Therapeutics
Jeremy Katzen, MD
Translational Therapeutics
James Gugger
Translational Therapeutics
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”